AU508970B2 - Tetrazole derivatives - Google Patents

Tetrazole derivatives

Info

Publication number
AU508970B2
AU508970B2 AU21895/77A AU2189577A AU508970B2 AU 508970 B2 AU508970 B2 AU 508970B2 AU 21895/77 A AU21895/77 A AU 21895/77A AU 2189577 A AU2189577 A AU 2189577A AU 508970 B2 AU508970 B2 AU 508970B2
Authority
AU
Australia
Prior art keywords
tetrazole derivatives
tetrazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU21895/77A
Other versions
AU2189577A (en
Inventor
P. F. and Partyka RA Joby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/748,851 external-priority patent/US4082751A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of AU2189577A publication Critical patent/AU2189577A/en
Application granted granted Critical
Publication of AU508970B2 publication Critical patent/AU508970B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU21895/77A 1976-02-13 1977-02-03 Tetrazole derivatives Expired AU508970B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65778776A 1976-02-13 1976-02-13
USUS657,787 1976-02-13
USUS748,851 1976-12-08
US05/748,851 US4082751A (en) 1976-02-13 1976-12-08 Therapeutic agents

Publications (2)

Publication Number Publication Date
AU2189577A AU2189577A (en) 1978-08-10
AU508970B2 true AU508970B2 (en) 1980-04-17

Family

ID=27097492

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21895/77A Expired AU508970B2 (en) 1976-02-13 1977-02-03 Tetrazole derivatives

Country Status (14)

Country Link
JP (1) JPS52118481A (en)
AU (1) AU508970B2 (en)
CA (1) CA1083152A (en)
CH (1) CH635339A5 (en)
DE (1) DE2705609A1 (en)
DK (1) DK149044C (en)
FI (1) FI62533C (en)
FR (1) FR2340943A1 (en)
GB (1) GB1541351A (en)
IE (1) IE44603B1 (en)
LU (1) LU76722A1 (en)
NL (1) NL173055C (en)
SE (1) SE433494B (en)
YU (1) YU41567B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
CN101747282A (en) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 Phenyl pyrimidone compounds, pharmaceutical compositions and preparation methods and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883653A (en) * 1972-10-24 1975-05-13 Pfizer Method of preventing asthmatic symptoms

Also Published As

Publication number Publication date
FI62533C (en) 1983-01-10
GB1541351A (en) 1979-02-28
JPS6139947B2 (en) 1986-09-06
SE433494B (en) 1984-05-28
DE2705609C2 (en) 1988-12-15
FI62533B (en) 1982-09-30
SE7701552L (en) 1977-09-23
YU41567B (en) 1987-10-31
DE2705609A1 (en) 1977-08-25
JPS52118481A (en) 1977-10-04
DK149044C (en) 1986-06-02
CH635339A5 (en) 1983-03-31
DK149044B (en) 1985-12-30
LU76722A1 (en) 1977-08-18
NL173055B (en) 1983-07-01
NL173055C (en) 1983-12-01
YU35477A (en) 1982-10-31
FI770427A (en) 1977-08-14
CA1083152A (en) 1980-08-05
FR2340943A1 (en) 1977-09-09
DK57377A (en) 1977-08-14
IE44603B1 (en) 1982-01-27
NL7701483A (en) 1977-08-16
FR2340943B1 (en) 1981-01-09
AU2189577A (en) 1978-08-10
IE44603L (en) 1977-08-13

Similar Documents

Publication Publication Date Title
AU509754B2 (en) Benazepine derivatives
AU517585B2 (en) Phenoxybenzyloxycarbonyl derivatives
AU507258B2 (en) Fluoroacacylresorcin derivatives
AU507742B2 (en) Tetrazoles
AU519213B2 (en) Tetrazole derivatives
AU504526B2 (en) Pipeazine derivatives
AU517829B2 (en) Morphanthridine derivatives
AU502122B2 (en) 5-0-acylated-imidazole-4-carboxamide derivatives
AU515192B2 (en) Quinoxaline-din-oxide derivatives
AU1675476A (en) Tetrazole derivatives
AU512647B2 (en) Solpenamide derivatives
AU508970B2 (en) Tetrazole derivatives
AU514803B2 (en) 4-phenylpipridine derivatives
AU513069B2 (en) 17-spirosiltine derivatives
AU507708B2 (en) Hydrazino-pyridazine derivatives
AU505150B2 (en) Triazolobenzazepine derivatives
AU510030B2 (en) Tetrazole derivatives
AU511948B2 (en) Nortropine-carbazate derivatives
AU503490B2 (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU519085B2 (en) 1-carba-2-penem derivatives
AU1858676A (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU518082B2 (en) Tetrazoles
AU515135B2 (en) Ribofuranosyl-imidazole derivatives
AU495377B2 (en) 3-nitropyrazole derivatives
AU508555B2 (en) 6-carboxy-flavone derivatives